| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $17.6B |
| Cost of Revenue | $55.9B | $51.7B | $51.0B | $45.6B | $26.9B | $22.2B | $17.2B | $15.3B |
| Gross Profit | $7.4B | $6.6B | $6.3B | $5.3B | $3.5B | $2.9B | $2.5B | $2.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.8B | $0.8B | $0.8B | $0.3B | $0.2B | $-0.1B | $0.3B | $0.3B |
| Net Income | $0.3B | $0.4B | $0.4B | $0.1B | $0.0B | $-0.1B | $0.2B | $0.2B |
| EPS (Basic) | $2.20 | $2.82 | $2.58 | $0.75 | $0.31 | $-1.01 | $1.61 | $1.95 |
| EPS (Diluted) | $2.18 | $2.79 | $2.54 | $0.74 | $0.30 | $-1.01 | $1.59 | $1.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.9B | $13.4B | $12.5B | $12.4B | $7.8B | $7.7B | $4.7B | $4.0B |
| Current Assets | $7.1B | $6.2B | $6.1B | $6.0B | $3.6B | $3.5B | $2.7B | $2.2B |
| Cash & Equivalents | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.4B | $0.0B | $0.0B |
| Total Liabilities | $13.4B | $9.3B | $8.8B | $9.1B | $5.7B | $5.7B | $3.4B | $2.9B |
| Current Liabilities | $4.5B | $3.8B | $3.6B | $3.6B | $2.5B | $2.6B | $1.7B | $1.5B |
| Stockholders' Equity | $4.5B | $4.1B | $3.7B | $3.3B | $2.1B | $2.0B | $1.3B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.2B | $0.8B | $0.3B | $0.1B | $0.6B | $0.3B | $0.4B |
| Investing Cash Flow | $-3.1B | $-0.7B | $-0.3B | $-1.9B | $-0.2B | $-2.1B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.5B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $1.9B | $-0.5B | $-0.5B | $1.6B | $-0.3B | $1.9B | $0.0B | $-0.2B |